On March 16, 2023, National Health Investors, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Equity Distribution Agreement”) with each of BMO Capital Markets Corp., BofA Securities, Inc., Capital One Securities, Inc., Huntington Securities, Inc., J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Regions Securities LLC, Stifel, Nicolaus & Company, Incorporated and Wells Fargo Securities, LLC, as sales agents, principals and/or (except in the case of Capital One Securities, Inc., Huntington Securities, Inc. and Stifel, Nicolaus & Company, Incorporated) Forward Sellers (as defined below) (in such capacity, each a “Sales Agent,” and together, the “Sales Agents”), and each of the Forward Purchasers (as defined below). Pursuant to the Equity Distribution Agreement, an initial aggregate gross sales price not to exceed $500,000,000 of the Company’s common stock (the “Common Stock”) may be offered and sold from time to time through the Sales Agents, as the Company’s sales agents, or, if applicable, as Forward Sellers, or directly to the Sales Agents, as principals.
The Common Stock sold in the offering will be issued pursuant to a prospectus supplement filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2023, and the accompanying base prospectus dated March 15, 2023 forming part of the Company’s shelf registration statement on Form S-3 (Registration No. 333-270557) filed with the SEC on March 15, 2023.
Subject to the terms and conditions of the Equity Distribution Agreement, the Sales Agents, whether acting as the Company’s sales agents or as Forward Sellers, will use commercially reasonable efforts, consistent with normal trading and sales practices and applicable law and regulations, to sell the Common Stock that may be designated by the Company (if acting as the Company’s sales agents) and the Common Stock borrowed from third parties (if acting as Forward Sellers), in each case on the terms and subject to the conditions of the Equity Distribution Agreement. Sales, if any, of the Common Stock made through the Sales Agents, as the Company’s sales agents or as Forward Sellers pursuant to the Equity Distribution Agreement, may be made in negotiated transactions, including transactions that are deemed to be “at the market” offerings as defined in Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), by means of ordinary brokers’ transactions at market prices prevailing at the time of sale, including sales made directly on the New York Stock Exchange, or sales made to or through a market maker and sales made through other securities exchanges or electronic communications networks. The Company also may sell Common Stock to any Sales Agent, as principal for its own account, at a price per share to be agreed upon at the time of sale. If the Company sells Common Stock to any Sales Agents, as principal, it will enter into a separate agreement with such Sales Agent, as applicable, setting forth the terms of such transaction.
The Company or any Sales Agent may at any time suspend an offering of Common Stock pursuant to the terms of the Equity Distribution Agreement. The offering of Common Stock pursuant to the Equity Distribution Agreement will terminate upon the earlier of (i) the sale of the Common Stock subject to the Equity Distribution Agreement and any terms agreement having an aggregate sale price equal to $500,000,000 and (ii) the termination of the Equity Distribution Agreement by the Company, the Sales Agents or the Forward Purchasers as permitted therein.
The Company made certain customary representations, warranties and covenants concerning the Company and the Common Stock in the Equity Distribution Agreement and also agreed to indemnify the Sales Agents and the Forward Purchasers against certain liabilities, including liabilities under the Securities Act.
The Equity Distribution Agreement provides that, in addition to the sale of Common Stock to or through the Sales Agents, the Company may enter into forward sale agreements with each of BMO Capital Markets Corp., BofA Securities, Inc., J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Regions Securities LLC and Wells Fargo Securities, LLC (or their respective affiliates), as forward purchasers (in such capacity, the “Forward Purchasers”), in a form attached as Exhibit G to the Equity Distribution Agreement (the “Forward Sale Agreements”). In connection with any Forward Sale Agreement, the relevant Forward Seller (or its affiliate) will, at the Company’s request, use commercially reasonable efforts, consistent with normal trading and sales practices and applicable law and regulations, to sell a number of shares of Common Stock equal to the number of shares of Common Stock underlying the particular Forward Sale Agreement.
In this Current Report on Form 8-K, a Sales Agent, when acting as sales agent for the relevant Forward Purchaser, is referred to, individually, as a “Forward Seller” and, collectively, as the “Forward Sellers.” Unless otherwise expressly stated or the context otherwise requires, references herein to the “related” or “relevant” Forward Purchaser mean, with respect to any Sales Agent, the affiliate of such Sales Agent that is acting as Forward Purchaser or, if applicable, such Sales Agent acting in its capacity as Forward Purchaser.
